4 Einträge gefunden

1. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

   1. Berg, Thomas
   2. Weich, Viola
   3. Teuber, Gerlinde
   4. Klinker, Hartwig
   5. Möller, Bernd
   6. Rasenack, Jens
   7. Hinrichsen, Holger

   2009 - Forschungsinformationssystem des UKE
2. Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

   1. von Wagner, Michael
   2. Hofmann, Wolf Peter
   3. Teuber, Gerlinde
   4. Berg, Thomas
   5. Goeser, Tobias
   6. Spengler, Ulrich
   7. Hinrichsen, Holger

   2008 - Forschungsinformationssystem des UKE
3. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

   1. Kronenberger, Bernd
   2. Berg, Thomas
   3. Herrmann, Eva
   4. Hinrichsen, Holger
   5. Gerlach, Tilman
   6. Buggisch, Peter
   7. Spengler, Ulrich

   2007 - Forschungsinformationssystem des UKE
4. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

   1. van Bömmel, Florian
   2. Zöllner, Bernhard
   3. Sarrazin, Christoph
   4. Spengler, Ulrich
   5. Hüppe, Dietrich
   6. Möller, Bernd
   7. Feucht, Heinz Hubert

   2006 - Forschungsinformationssystem des UKE